Literature DB >> 15308600

Diagnostic probes for Bacillus anthracis spores selected from a landscape phage library.

Jennifer Brigati1, David D Williams, Iryna B Sorokulova, Viswaprakash Nanduri, I-Hsuan Chen, Charles L Turnbough, Valery A Petrenko.   

Abstract

BACKGROUND: Recent use of Bacillus anthracis spores as a bioweapon has highlighted the need for a continuous monitoring system. Current monitoring systems rely on antibody-derived probes, which are not hardy enough to withstand long-term use under extreme conditions. We describe new, phage-derived probes that can be used as robust substitutes for antibodies.
METHODS: From a landscape phage library with random octapeptides displayed on all copies of the major phage coat protein of the phage fd-tet, we selected clones that bound to spores of B. anthracis (Sterne strain). ELISA, micropanning, and coprecipitation assays were used to evaluate the specificity and selectivity with which these phage bound to B. anthracis spores.
RESULTS: Peptides on the selected clones directed binding of the phage to B. anthracis spores. Most clones exhibited little or no binding to spores of distantly related Bacillus species, but some binding was observed with spores of closely related species. Our most specific spore-binding phage displayed a peptide EPRLSPHS (several thousand peptides per phage) and bound 3.5- to 70-fold better to spores of B. anthracis Sterne than to spores of other Bacillus species.
CONCLUSIONS: The selected phage probes bound preferentially to B. anthracis Sterne spores compared with other Bacillus species. These phage could possibly be further developed into highly specific and robust probes suitable for long-term use in continuous monitoring devices and biosorbents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308600     DOI: 10.1373/clinchem.2004.038018

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Landscape Phage as a Molecular Recognition Interface for Detection Devices.

Authors:  Valery A Petrenko
Journal:  Microelectronics J       Date:  2008-02

Review 4.  Virus-based chemical and biological sensing.

Authors:  Chuanbin Mao; Aihua Liu; Binrui Cao
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Landscape phage ligands for PC3 prostate carcinoma cells.

Authors:  P K Jayanna; D Bedi; P Deinnocentes; R C Bird; V A Petrenko
Journal:  Protein Eng Des Sel       Date:  2010-02-25       Impact factor: 1.650

Review 6.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

7.  Application of filamentous phages in environment: A tectonic shift in the science and practice of ecorestoration.

Authors:  Radhey Shyam Sharma; Swagata Karmakar; Pankaj Kumar; Vandana Mishra
Journal:  Ecol Evol       Date:  2019-01-25       Impact factor: 2.912

8.  Genetic evidence for the involvement of the S-layer protein gene sap and the sporulation genes spo0A, spo0B, and spo0F in Phage AP50c infection of Bacillus anthracis.

Authors:  Roger D Plaut; John W Beaber; Jason Zemansky; Ajinder P Kaur; Matroner George; Biswajit Biswas; Matthew Henry; Kimberly A Bishop-Lilly; Vishwesh Mokashi; Ryan M Hannah; Robert K Pope; Timothy D Read; Scott Stibitz; Richard Calendar; Shanmuga Sozhamannan
Journal:  J Bacteriol       Date:  2013-12-20       Impact factor: 3.490

9.  Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy.

Authors:  Naveen Gandra; Gopal Abbineni; Xuewei Qu; Yanyan Huai; Li Wang; Chuanbin Mao
Journal:  Small       Date:  2012-10-09       Impact factor: 13.281

Review 10.  Phage protein-targeted cancer nanomedicines.

Authors:  V A Petrenko; P K Jayanna
Journal:  FEBS Lett       Date:  2013-11-20       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.